ELV vs UNH
ELV and UNH side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ELVELEVANCE HEALTH, INC. | UNHUnitedHealth Group Incorporated |
|---|---|---|
| Market cap | $85.34B | $396.80B |
| P/E (TTM) | 17.4 | 32.9 |
| P/B | 1.90 | 12.02 |
| P/S | 0.4x | 0.9x |
| Dividend yield | — | 1.99% |
| Revenue | $201.11B(TTM) | $449.71B(TTM) |
| Revenue growth (YoY) | 12.5% | 11.8% |
| Net income | $4.96B(TTM) | $12.04B(TTM) |
| Earnings growth (YoY) | -5.3% | -16.3% |
| EPS, diluted | $22.61(TTM) | $13.28(TTM) |
| EBIT margin | 3.6% | 4.2% |
| ROE | 12.6% | 36.5% |
| ROIC | 9.3% | 19.9% |
| 1y total return | +45.0% | +58.0% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: ELV frente a UNH
| Métrica | ELV | UNH |
|---|---|---|
| Valor final | $32.4K | $41.5K |
| Retorno total | +223.6% | +315.1% |
| CAGR | +12.0% | +14.8% |
| Volatilidad | 31.0% | 29.9% |
| Sharpe | 0.40 | 0.49 |
| Sortino | 0.56 | 0.67 |
| Caída máxima | -50.4% | -61.4% |
Basado en 2600 días de negociación comunes, 2016-03-17 → 2026-07-21 · tasa libre de riesgo 3.87% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)